Medication
Cytisine
A plant-derived medication that works similarly to varenicline and has a long history of use in some countries.
What it is
Cytisine is a plant-based partial nicotine-receptor agonist used for smoking cessation for decades, particularly in Central and Eastern Europe, and available in more markets in recent years.
How it works
Like varenicline, it stimulates nicotine receptors partially, reducing withdrawal and blocking nicotine reward. Treatment courses are typically shorter (around 3–4 weeks).
Evidence
Cochrane reviews found cytisine increases quit success versus placebo, and a 2019 randomized trial found it non-inferior to varenicline with fewer adverse events. It is among the most cost-effective cessation medications.
Evidence strength: Moderate
Reported community experiences
Community reports of cytisine are less common in English-language communities; where reported, people describe reduced craving with nausea and sleep disturbance as notable side effects. Community records are being compiled in the Experience Database.
Practical considerations
- Availability varies by country: it is prescription-only in some markets and pharmacy-sold in others
- Discuss use with a pharmacist or doctor
- Report side effects as with any medication
Limitations
Information only, not individual advice. Availability, regulation and dosing differ between countries; check local status with a healthcare professional.
This method involves a medication. This page provides information only — it is not a prescription, dosing advice or a substitute for professional medical judgment. See the medication evidence page and talk to a healthcare professional.
Community-reported experiences are de-identified individual accounts and do not constitute scientific evidence or medical advice.